CINCINNATI FINANCIAL CORP CINF Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000020286-25-000029
cik 20286
name CINCINNATI FINANCIAL CORP
sic 6331
countryba US
stprba OH
cityba FAIRFIELD
zipba 45014
bas1 6200 S GILMORE RD
bas2
baph 5138702000
countryma US
stprma OH
cityma CINCINNATI
zipma 45250
mas1 P.O. BOX 145496
mas2
countryinc US
stprinc OH
ein 310746871
former
changed
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250428
accepted 2025-04-28 16:15:00.0
prevrpt 0
detail 1
instance cinf-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000020286-25-000029 20241231 Accrued Investment Income Receivable 222000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 2274000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 645000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 27000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20240331 Change In Life Policy Reserves Reinsurance Recoverable And Other Net Of Tax -37000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20240331 Common Stock Dividends Per Share Declared 0.8100 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Deferred Income Tax Expense Benefit 137000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20231231 Deferred Policy Acquisition Costs 52000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20240331 Deferred Policy Acquisition Costs 52000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20250331 Equity Securities Fv Ni Cost 3964000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Equity Securities Fv Ni Current And Noncurrent 11185000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Gain Loss On Investments -2000000.0000 USD 1 us-gaap/2025 Investment Type= Debt Securities;
0000020286-25-000029 20250331 Gain Loss On Investments -72000000.0000 USD 1 us-gaap/2025 Investment Type= Equity Securities;
0000020286-25-000029 20250331 Income Taxes Paid Net 2000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Increase Decrease In Deferred Income Taxes 55000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Increase Decrease In Future Policy Benefit Reserves 26000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decrease In Other Operating Assets 22000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Increase Decrease In Other Operating Liabilities -161000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decrease In Other Operating Liabilities -135000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Interest Credited To Policy Owner Account 11000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Investments 28378000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Liability For Claims And Claims Adjustment Expense 68000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20240331 Liability For Future Policy Benefits 1054000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Term Life Insurance;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 1051000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Term Life Insurance;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 1575000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 412000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Whole Life Insurance;
0000020286-25-000029 20240331 Net Cash Provided By Used In Investing Activities -355000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Net Income Loss 755000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Net Investment Income 280000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax 0.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax 53000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax -11000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Other Cost And Expense Operating 11000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Other Income 4000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 79000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 82000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 99000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Premiums Earned Net 1179000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Premiums Earned Net 2264000000.0000 USD 1 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20240331 Proceeds From Payments For Other Financing Activities -57000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Reinsurance Recoverable 808000000.0000 USD 0 0000020286-25-000029
0000020286-25-000029 20240331 Revenues 140000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Revenues 857000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Separate Accounts Liability 927000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20250331 Separate Accounts Liability 959000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Short Term Investments 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0000020286-25-000029 20231231 Stockholders Equity -435000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000020286-25-000029 20231231 Stockholders Equity 397000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20231231 Stockholders Equity 13084000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20240331 Stockholders Equity 397000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20240331 Stockholders Equity -2459000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20241231 Stockholders Equity 1502000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20241231 Stockholders Equity 397000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20241231 Stockholders Equity 14869000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20250331 Stockholders Equity 57000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000020286-25-000029 20250331 Stockholders Equity 53000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Gain Loss On Life Policy Reserves Reinsurance Recoverable And Other;
0000020286-25-000029 20240331 Stock Issued During Period Value Stock Options Exercised -6000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -271000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Additions To Contract Holders Funds 19000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Assets 5927000000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Assets 1144000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 8633000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 4692000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 27000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 619000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Common Stock Value 397000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Comprehensive Income Net Of Tax -52000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 27000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20231231 Deferred Policy Acquisition Costs 1093000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20231231 Deferred Policy Acquisition Costs 749000000.0000 USD 0 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20240331 Deferred Policy Acquisition Costs 796000000.0000 USD 0 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20241231 Deferred Policy Acquisition Costs 356000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20250331 Deferred Policy Acquisition Costs 1297000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Deferred Policy Acquisition Costs 248000000.0000 USD 0 us-gaap/2025 Product Or Service= Term Life Insurance;
0000020286-25-000029 20250331 Deferred Policy Acquisition Costs 51000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20250331 Dividends Common Stock Cash 135000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20240331 Gain Loss On Investments 602000000.0000 USD 1 us-gaap/2025 Investment Type= Equity Securities;
0000020286-25-000029 20250331 Gain Loss On Investments -67000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve 196000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Insurance Commissions And Fees 1000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Interest Credited To Policy Owner Account 11000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Liabilities 22566000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Liabilities And Stockholders Equity 37276000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Liability For Future Policy Benefits 595000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Deferred Fixed Annuity;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 109000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Other Longduration Insurance Product Line;
0000020286-25-000029 20250331 Long Term Debt And Capital Lease Obligations 853000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Net Cash Provided By Used In Financing Activities -286000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax -44000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Other Comprehensive Income Loss Net Of Tax -7000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Payments For Proceeds From Other Investing Activities 16000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Payments For Repurchase Of Common Stock 75000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 79000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Premiums Earned Net 183000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20250331 Premiums Earned Net 162000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Proceeds From Sale Of Available For Sale Securities Debt 464000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Revenues 2749000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Separate Account Assets 876000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20241231 Separate Account Assets 876000000.0000 USD 0 us-gaap/2025 Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20250331 Separate Account Assets 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20241231 Short Term Investments 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0000020286-25-000029 20250331 Short Term Investments Available For Sale Amortized Cost Basis 100000000.0000 USD 0 0000020286-25-000029
0000020286-25-000029 20240331 Stockholders Equity -491000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000020286-25-000029 20241231 Stockholders Equity -309000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000020286-25-000029 20250331 Stockholders Equity 397000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20250331 Stock Issued During Period Value Stock Options Exercised 6000000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20240331 Underwriting Acquisition And Insurance Expenses 58000000.0000 USD 1 0000020286-25-000029 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20241231 Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 347000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Assets 27967000000.0000 USD 0 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 4721000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 551000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 4721000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 645000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 4692000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20240331 Benefits Losses And Expenses 1982000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Benefits Losses And Expenses 2387000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Capital Lease Obligations Incurred 4000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 983000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 27000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Commitments And Contingencies USD 0 us-gaap/2025
0000020286-25-000029 20250331 Common Stock Dividends Per Share Declared 0.8700 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Common Stock Shares Outstanding 156400000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20231231 Deferred Policy Acquisition Costs 344000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20241231 Deferred Policy Acquisition Costs 8000000.0000 USD 0 us-gaap/2025 Product Or Service= Deferred Fixed Annuity;
0000020286-25-000029 20250331 Earnings Per Share Diluted -0.5700 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Equity Securities Fv Ni Current And Noncurrent 11118000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Gain Loss On Sale Of Investments 608000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Gain Loss On Sale Of Investments -74000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Income Tax Expense Benefit -38000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Increase Decreasein Premiumsand Reinsurancereceivable 203000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20250331 Liabilities Assumed1 100000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Liability For Future Policy Benefits 116000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Structured Settlement Annuity;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 1554000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 405000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Whole Life Insurance;
0000020286-25-000029 20241231 Long Term Debt And Capital Lease Obligations 850000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Net Cash Provided By Used In Financing Activities -225000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Net Cash Provided By Used In Investing Activities -58000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Net Income Loss -90000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20240331 Other Income 3000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Other Income 4000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Other Investments 713000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Payments To Acquire Proceeds From Sale And Collection Of Finance Receivables -2000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 1349000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 1270000000.0000 USD 1 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 81000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Premiums Earned Net 79000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20250331 Premiums Earned Net 80000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Premiums Receivable At Carrying Value 3163000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Prepaid Reinsurance Premiums 93000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Proceeds From Stock Options Exercised 3000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Proceeds From Stock Options Exercised 4000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Property Plant And Equipment Net 214000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Retained Earnings Accumulated Deficit 14644000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Revenues 2935000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Revenues 2566000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Revenues 2337000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Separate Account Assets 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20250331 Separate Account Assets 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20240331 Shares Acquired During Period Value Employee Share Based Compensation Plans 7000000.0000 USD 1 0000020286-25-000029 Equity Components= Treasury Stock Common;
0000020286-25-000029 20241231 Short Term Investments 298000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0000020286-25-000029 20241231 Short Term Investments Available For Sale Amortized Cost Basis 298000000.0000 USD 0 0000020286-25-000029
0000020286-25-000029 20231231 Stockholders Equity -447000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000020286-25-000029 20231231 Stockholders Equity -2385000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20240331 Stockholders Equity 13712000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20241231 Stockholders Equity -2524000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20250331 Stockholders Equity 13718000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Stockholders Equity -381000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000020286-25-000029 20250331 Stockholders Equity -271000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000020286-25-000029 20250331 Treasury Stock Value 2563000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Withdrawal From Contract Holders Funds 60000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Withdrawal From Contract Holders Funds 40000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Accrued Investment Income Receivable 224000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 354000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Cash And Cash Equivalents At Carrying Value 983000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Additional Paid In Capital Common Stock 1511000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Additional Paid In Capital Common Stock 1502000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Assets 27887000000.0000 USD 0 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Assets 6481000000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 15956000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 8380000000.0000 USD 0 us-gaap/2025 Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 226000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 216000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20250331 Benefits Losses And Expenses 2694000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Capital Lease Obligations Incurred 8000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Change In Life Policy Reserves Reinsurance Recoverable And Other Tax 10000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20231231 Common Stock Shares Outstanding 157000000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20250331 Common Stock Shares Outstanding 156300000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20250331 Common Stock Value 397000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Current Income Tax Expense Benefit 61000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Current Income Tax Expense Benefit -42000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 16735000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 8652000000.0000 USD 0 us-gaap/2025 Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20241231 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 228000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20241231 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 2282000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20250331 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 17009000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 217000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20250331 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 4973000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20250331 Deferred Income Tax Expense Benefit 4000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Deferred Policy Acquisition Costs 1143000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Deferred Policy Acquisition Costs 238000000.0000 USD 0 us-gaap/2025 Product Or Service= Term Life Insurance;
0000020286-25-000029 20250331 Deferred Policy Acquisition Costs 937000000.0000 USD 0 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20240331 Earnings Per Share Diluted 4.7800 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Gain Loss On Investments -10000000.0000 USD 1 us-gaap/2025 Investment Type= Debt Securities;
0000020286-25-000029 20240331 Increase Decrease In Unearned Premiums 279000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decrease In Unearned Premiums 255000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Interest Expense 13000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Interest Expense 13000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Investments 28481000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20231231 Liability For Claims And Claims Adjustment Expense 8975000000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 2968000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Net Investment Income 280000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Notes Payable 25000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Other Assets 903000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Other Comprehensive Income Loss Net Of Tax 38000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Other Income 3000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 1968000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 1887000000.0000 USD 1 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20240331 Premiums Earned Net 2071000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Premiums Earned Net 2344000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Proceeds From Payments For Other Financing Activities -36000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Proceeds From Sale Of Equity Securities Fv Ni 266000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Property Plant And Equipment Net 216000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Reinsurance Recoverable 523000000.0000 USD 0 0000020286-25-000029
0000020286-25-000029 20250331 Revenues 213000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Separate Accounts Liability 952000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Shares Acquired During Period Employee Share Based Compensation Plans Shares 0.0000 shares 1 0000020286-25-000029 Equity Components= Common Stock;
0000020286-25-000029 20241231 Short Term Investments 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0000020286-25-000029 20250331 Stockholders Equity 14644000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20240331 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20250331 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20240331 Treasury Stock Value Acquired Cost Method 75000000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20240331 Underwriting Acquisition And Insurance Expenses 616000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20250331 Underwriting Acquisition And Insurance Expenses 44000000.0000 USD 1 0000020286-25-000029 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Underwriting Acquisition And Insurance Expenses 76000000.0000 USD 1 0000020286-25-000029 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20241231 Unearned Premiums 4813000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Stockholders Equity 13935000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Assets 37276000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 551000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 8380000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 30000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 30000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 2274000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20231231 Stockholders Equity 1437000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 2310000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 2310000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20250331 Common Stock Par Or Stated Value Per Share 2.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2025
0000020286-25-000029 20240331 Common Stock Shares Outstanding 156500000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20240331 Comprehensive Income Net Of Tax 748000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 4976000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0000020286-25-000029 20231231 Deferred Policy Acquisition Costs 8000000.0000 USD 0 us-gaap/2025 Product Or Service= Deferred Fixed Annuity;
0000020286-25-000029 20231231 Deferred Policy Acquisition Costs 236000000.0000 USD 0 us-gaap/2025 Product Or Service= Term Life Insurance;
0000020286-25-000029 20241231 Deferred Policy Acquisition Costs 52000000.0000 USD 0 us-gaap/2025 Product Or Service= Whole Life Insurance;
0000020286-25-000029 20250331 Deferred Policy Acquisition Costs 360000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20250331 Gain Loss On Investments -67000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 953000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decrease In Deferred Policy Acquisition Costs 55000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve 777000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Increase Decrease In Other Operating Assets 8000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Insurance Commissions And Fees 4000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Insurance Commissions And Fees 1000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Insurance Commissions And Fees 2000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Liabilities Assumed1 97000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Liability For Claims And Claims Adjustment Expense 9178000000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000020286-25-000029 20241231 Liability For Claims And Claims Adjustment Expense 10003000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Liability For Claims And Claims Adjustment Expense 9937000000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000020286-25-000029 20250331 Liability For Claims And Claims Adjustment Expense 73000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 98000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Other Longduration Insurance Product Line;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 1064000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Term Life Insurance;
0000020286-25-000029 20241231 Notes Receivable Net 120000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Payments For Proceeds From Other Investing Activities 27000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Payments To Acquire Equity Securities Fv Ni 226000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 379000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 735000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 81000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 846000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Premiums Earned Net 1082000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Premiums Earned Net 1992000000.0000 USD 1 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20240331 Premiums Earned Net 139000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Premiums Earned Net 79000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Proceeds From Sale Of Equity Securities Fv Ni 17000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Purchase Of Treasury Shares Non Cash 17000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20240331 Revenues 1083000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Separate Account Assets 952000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Separate Accounts Liability 952000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20231231 Stockholders Equity -10000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Gain Loss On Life Policy Reserves Reinsurance Recoverable And Other;
0000020286-25-000029 20240331 Stockholders Equity 22000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000020286-25-000029 20240331 Stockholders Equity 27000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Gain Loss On Life Policy Reserves Reinsurance Recoverable And Other;
0000020286-25-000029 20240331 Stockholders Equity -442000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000020286-25-000029 20250331 Treasury Stock Shares Acquired 300000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20240331 Underwriting Acquisition And Insurance Expenses 38000000.0000 USD 1 0000020286-25-000029 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Underwriting Acquisition And Insurance Expenses 23000000.0000 USD 1 0000020286-25-000029 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Underwriting Acquisition And Insurance Expenses 210000000.0000 USD 1 0000020286-25-000029 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Unearned Premiums 5068000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Treasury Stock Value 2524000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Additions To Contract Holders Funds 14000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20241231 Assets 1029000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 226000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1010000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Change In Short Term Investments 0.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20241231 Commitments And Contingencies USD 0 us-gaap/2025
0000020286-25-000029 20250331 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 8833000000.0000 USD 0 us-gaap/2025 Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20241231 Deferred Income Tax Liabilities 1476000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Deferred Income Tax Liabilities 1489000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20231231 Deferred Policy Acquisition Costs 48000000.0000 USD 0 us-gaap/2025 Product Or Service= Whole Life Insurance;
0000020286-25-000029 20240331 Deferred Policy Acquisition Costs 347000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20241231 Deferred Policy Acquisition Costs 886000000.0000 USD 0 us-gaap/2025 Business Segments= Consolidated Property And Casualty Insurance;
0000020286-25-000029 20240331 Earnings Per Share Basic 4.8200 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Income Tax Expense Benefit 198000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decreasein Premiumsand Reinsurancereceivable 502000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20250331 Insurance Commissions And Fees 1000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Liabilities And Stockholders Equity 36501000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Liability For Future Policy Benefits 418000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Whole Life Insurance;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 1406000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 108000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Other Longduration Insurance Product Line;
0000020286-25-000029 20240331 Net Income Loss 755000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20250331 Notes Payable 25000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Other Assets 828000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Other Comprehensive Income Loss Net Of Tax -7000000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000020286-25-000029 20250331 Other Comprehensive Income Loss Net Of Tax 38000000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000020286-25-000029 20241231 Other Liabilities 1487000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Payments Of Dividends Common Stock 125000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Payments To Acquire Available For Sale Securities Debt 838000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Payments To Acquire Available For Sale Securities Debt 717000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Payments To Acquire Proceeds From Sale And Collection Of Finance Receivables 3000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20240331 Payments To Acquire Property Plant And Equipment 7000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Premiums Earned Net 80000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance;
0000020286-25-000029 20250331 Proceeds From Sale Of Available For Sale Securities Debt 497000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Revenues 81000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Separate Account Assets 895000000.0000 USD 0 us-gaap/2025 Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20240331 Shares Acquired During Period Employee Share Based Compensation Plans Shares 100000.0000 shares 1 0000020286-25-000029 Equity Components= Common Stock;
0000020286-25-000029 20241231 Short Term Investments 298000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Short Term Investments 100000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0000020286-25-000029 20231231 Stockholders Equity 22000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000020286-25-000029 20240331 Stockholders Equity 12654000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Stockholders Equity 1446000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20250331 Stockholders Equity -2563000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20240331 Stock Issued During Period Value Stock Options Exercised 8000000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20250331 Treasury Stock Common Shares 42000000.0000 shares 0 us-gaap/2025
0000020286-25-000029 20250331 Underwriting Acquisition And Insurance Expenses 702000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -309000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 16182000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 226000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 16523000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 216000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 216000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 16307000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0000020286-25-000029 20250331 Cash And Cash Equivalents At Carrying Value 1010000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -288000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Change In Life Policy Reserves Reinsurance Recoverable And Other Net Of Tax 14000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20250331 Change In Short Term Investments 200000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20241231 Common Stock Par Or Stated Value Per Share 2.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Common Stock Shares Issued 198300000.0000 shares 0 us-gaap/2025
0000020286-25-000029 20241231 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 30000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Government Debt Securities;
0000020286-25-000029 20250331 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 649000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20240331 Deferred Policy Acquisition Costs 49000000.0000 USD 0 us-gaap/2025 Product Or Service= Whole Life Insurance;
0000020286-25-000029 20241231 Deferred Policy Acquisition Costs 245000000.0000 USD 0 us-gaap/2025 Product Or Service= Term Life Insurance;
0000020286-25-000029 20241231 Deferred Policy Acquisition Costs 51000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20250331 Deferred Policy Acquisition Costs 8000000.0000 USD 0 us-gaap/2025 Product Or Service= Deferred Fixed Annuity;
0000020286-25-000029 20240331 Depreciation Amortization And Other 34000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20241231 Equity Securities Fv Ni Cost 3953000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Income Taxes Paid Net 106000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Increase Decrease In Deferred Policy Acquisition Costs 50000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Insurance Commissions And Fees 1000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Insurance Commissions And Fees 1000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Insurance Commissions And Fees 5000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Liabilities 23558000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Liability For Claims And Claims Adjustment Expense 10780000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Liability For Claims And Claims Adjustment Expense 10707000000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 586000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Universal Life;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 1393000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 116000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Structured Settlement Annuity;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 587000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Universal Life;
0000020286-25-000029 20250331 Liability For Future Policy Benefits 99000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Life Policy Reserves; Product Or Service= Other Longduration Insurance Product Line;
0000020286-25-000029 20250331 Net Cash Provided By Used In Operating Activities 310000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Net Income Loss -90000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Net Investment Income 245000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Net Investment Income 245000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax -1000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Actuarial Loss And Prior Service Cost Arising During Period Tax 0.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20240331 Other Cost And Expense Operating 4000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Other Investments 740000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Other Liabilities 1416000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Payments For Repurchase Of Common Stock 42000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 719000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Policyholder Benefits And Claims Incurred Net 90000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Policyholder Benefits And Claims Incurred Net 207000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20250331 Premiums Earned Net 698000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Premiums Receivable At Carrying Value 2969000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 14000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 15000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20241231 Assets 36501000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20241231 Assets 1658000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Assets 1684000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S Government Agencies Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20250331 Available For Sale Securities Debt Securities 8633000000.0000 USD 0 us-gaap/2025 Financial Instrument= Corporate Bond Securities;
0000020286-25-000029 20240331 Benefits Losses And Expenses 1825000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000020286-25-000029 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 907000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Change In Life Policy Reserves Reinsurance Recoverable And Other Tax -3000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20241231 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2025
0000020286-25-000029 20250331 Common Stock Shares Issued 198300000.0000 shares 0 us-gaap/2025
0000020286-25-000029 20241231 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 567000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0000020286-25-000029 20250331 Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss 2310000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Government Sponsored Enterprises Debt Securities;
0000020286-25-000029 20240331 Deferred Policy Acquisition Costs 8000000.0000 USD 0 us-gaap/2025 Product Or Service= Deferred Fixed Annuity;
0000020286-25-000029 20241231 Deferred Policy Acquisition Costs 1242000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Deferred Policy Acquisition Costs 53000000.0000 USD 0 us-gaap/2025 Product Or Service= Whole Life Insurance;
0000020286-25-000029 20250331 Depreciation Amortization And Other 47000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20240331 Dividends Common Stock Cash 127000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000020286-25-000029 20250331 Earnings Per Share Basic -0.5700 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Gain Loss On Investments 612000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Gain Loss On Investments 612000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Segment Of C I N F; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -128000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decrease In Deferred Income Taxes 59000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Increase Decrease In Future Policy Benefit Reserves 5000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Insurance Commissions And Fees 1000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Insurance Commissions And Fees 1000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Liability For Future Policy Benefits 2960000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Liability For Future Policy Benefits 582000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Investmentcontractreserves; Product Or Service= Deferred Fixed Annuity;
0000020286-25-000029 20240331 Net Cash Provided By Used In Operating Activities 353000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Notes Receivable Net 122000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Actuarial Loss And Prior Service Cost Arising During Period Tax 0.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax 14000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Payments Of Dividends Common Stock 116000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Payments To Acquire Equity Securities Fv Ni 22000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20250331 Payments To Acquire Property Plant And Equipment 3000000.0000 USD 1 us-gaap/2025
0000020286-25-000029 20240331 Premiums Earned Net 588000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Premiums Earned Net 225000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000020286-25-000029 20250331 Purchase Of Treasury Shares Non Cash 13000000.0000 USD 1 0000020286-25-000029
0000020286-25-000029 20241231 Retained Earnings Accumulated Deficit 14869000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20240331 Revenues 80000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Revenues 589000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Revenues 1181000000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Revenues 163000000.0000 USD 1 us-gaap/2025 Business Segments= Excessand Surplus Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Separate Account Assets 959000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Separate Accounts Liability 959000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20250331 Shares Acquired During Period Value Employee Share Based Compensation Plans 3000000.0000 USD 1 0000020286-25-000029 Equity Components= Treasury Stock Common;
0000020286-25-000029 20250331 Stockholders Equity Other -1000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20250331 Stock Issued During Period Shares Stock Options Exercised 200000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20241231 Treasury Stock Common Shares 41900000.0000 shares 0 us-gaap/2025
0000020286-25-000029 20240331 Treasury Stock Shares Acquired 700000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20250331 Treasury Stock Value Acquired Cost Method 42000000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0000020286-25-000029 20240331 Underwriting Acquisition And Insurance Expenses 22000000.0000 USD 1 0000020286-25-000029 Business Segments= Life Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20240331 Underwriting Acquisition And Insurance Expenses 173000000.0000 USD 1 0000020286-25-000029 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Prepaid Reinsurance Premiums 70000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Revenues 699000000.0000 USD 1 us-gaap/2025 Business Segments= Personal Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20241231 Separate Account Assets 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20250331 Separate Account Assets 895000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Investment Type= Taxable Fixed Maturities;
0000020286-25-000029 20231231 Separate Accounts Liability 925000000.0000 USD 0 us-gaap/2025 Product Or Service= Universal Life;
0000020286-25-000029 20250331 Short Term Investments 100000000.0000 USD 0 us-gaap/2025
0000020286-25-000029 20250331 Short Term Investments 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0000020286-25-000029 20241231 Stockholders Equity 58000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000020286-25-000029 20241231 Stockholders Equity 67000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Gain Loss On Life Policy Reserves Reinsurance Recoverable And Other;
0000020286-25-000029 20241231 Stockholders Equity -434000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000020286-25-000029 20250331 Stockholders Equity 1511000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20240331 Stockholders Equity Other -1000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20240331 Stock Issued During Period Shares Stock Options Exercised 300000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0000020286-25-000029 20250331 Stock Issued During Period Value Stock Options Exercised -7000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000020286-25-000029 20240331 Underwriting Acquisition And Insurance Expenses 325000000.0000 USD 1 0000020286-25-000029 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;
0000020286-25-000029 20250331 Underwriting Acquisition And Insurance Expenses 349000000.0000 USD 1 0000020286-25-000029 Business Segments= Commercial Lines Insurance; Consolidation Items= Operating Segments;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Equity Securities Fv Ni Current And Noncurrent us-gaap/2025 0 0 monetary I D Equity Securities, FV-NI Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).
Increase Decrease In Deferred Income Taxes us-gaap/2025 0 0 monetary D C Increase (Decrease) in Deferred Income Taxes The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Cash And Cash Equivalents At Carrying Value us-gaap/2025 0 0 monetary I D Cash and Cash Equivalent Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Earnings Per Share Diluted us-gaap/2025 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Interest Credited To Policy Owner Account us-gaap/2025 0 0 monetary D D Interest Credited to Policy Owner Account Amount of expense for unpaid portion of interest credited to policy owner account.
Property Plant And Equipment Net us-gaap/2025 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Benefits Losses And Expenses us-gaap/2025 0 0 monetary D D Benefits, Losses and Expenses The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.
Commitments And Contingencies us-gaap/2025 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve us-gaap/2025 0 0 monetary D D Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.
Other Income us-gaap/2025 0 0 monetary D C Other Income Amount of revenue and income classified as other.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Short Term Investments us-gaap/2025 0 0 monetary I D Short-Term Investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Available For Sale Securities Debt Securities us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Depreciation Amortization And Other 0000020286-25-000029 1 0 monetary D D Depreciation, amortization and other Depreciation, amortization and other
Increase Decreasein Premiumsand Reinsurancereceivable 0000020286-25-000029 1 0 monetary D C Increase (Decrease ) in Premiums and Reinsurance receivable Increase (Decrease ) in Premiums and Reinsurance receivable
Comprehensive Income Net Of Tax us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Accrued Investment Income Receivable us-gaap/2025 0 0 monetary I D Accrued Investment Income Receivable Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Common Stock Dividends Per Share Declared us-gaap/2025 0 0 perShare D Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding.
Notes Receivable Net us-gaap/2025 0 0 monetary I D Financing Receivable, after Allowance for Credit Loss Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.
Other Cost And Expense Operating us-gaap/2025 0 0 monetary D D Other Cost and Expense, Operating The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
Other Investments us-gaap/2025 0 0 monetary I D Other Investments Amount of investments classified as other.
Payments For Repurchase Of Common Stock us-gaap/2025 0 0 monetary D C Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period.
Payments For Proceeds From Other Investing Activities us-gaap/2025 0 0 monetary D C Payment for (Proceeds from) Other Investing Activity Amount of cash (inflow) outflow from investing activity, classified as other.
Change In Life Policy Reserves Reinsurance Recoverable And Other Net Of Tax 0000020286-25-000029 1 0 monetary D D Change in life policy reserves, reinsurance recoverable and other, net of tax Change in life policy reserves, reinsurance recoverable and other, net of tax
Short Term Investments Available For Sale Amortized Cost Basis 0000020286-25-000029 1 0 monetary I D Short-term investments, available-for-sale, amortized cost basis Amortized cost of short-term investments measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Net Investment Income us-gaap/2025 0 0 monetary D C Net Investment Income Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.
Other Assets us-gaap/2025 0 0 monetary I D Other Assets Amount of assets classified as other.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax us-gaap/2025 0 0 monetary D D OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Payments To Acquire Available For Sale Securities Debt us-gaap/2025 0 0 monetary D C Payments to Acquire Debt Securities, Available-for-Sale Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Premiums Earned Net us-gaap/2025 0 0 monetary D C Premiums Earned, Net Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.
Premiums Receivable At Carrying Value us-gaap/2025 0 0 monetary I D Premiums Receivable, Net The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.
Prepaid Reinsurance Premiums us-gaap/2025 0 0 monetary I D Prepaid Reinsurance Premiums The unexpired portion of premiums ceded on policies in force as of the balance sheet date.
Shares Acquired During Period Employee Share Based Compensation Plans Shares 0000020286-25-000029 1 0 shares D Shares acquired during period, Employee Share-Based Compensation Plans, Shares Shares acquired during period, Employee Share-Based Compensation Plans, Shares
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Other Operating Assets us-gaap/2025 0 0 monetary D C Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other.
Payments To Acquire Property Plant And Equipment us-gaap/2025 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Gain Loss On Sale Of Investments us-gaap/2025 0 0 monetary D C Gain (Loss) on Sale of Investments The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.
Increase Decrease In Other Operating Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Other Operating Liabilities Amount of increase (decrease) in operating liabilities classified as other.
Increase Decrease In Unearned Premiums us-gaap/2025 0 0 monetary D D Increase (Decrease) in Unearned Premiums Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.
Insurance Commissions And Fees us-gaap/2025 0 0 monetary D C Insurance Commissions and Fees Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products.
Interest Expense us-gaap/2025 0 0 monetary D D Interest Expense, Operating and Nonoperating Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.
Payments To Acquire Equity Securities Fv Ni us-gaap/2025 0 0 monetary D C Payments to Acquire Equity Securities, FV-NI Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Stock Issued During Period Value Stock Options Exercised us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Reinsurance Recoverable 0000020286-25-000029 1 0 monetary I D Reinsurance Recoverable Reinsurance Recoverable
Separate Account Assets us-gaap/2025 0 0 monetary I D Separate Account Asset Amount of asset at fair value held for benefit of separate account policyholder.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Deferred Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Deferred Policy Acquisition Costs us-gaap/2025 0 0 monetary I D Deferred Policy Acquisition Cost Amount of deferred policy acquisition cost capitalized on contract remaining in force.
Dividends Common Stock Cash us-gaap/2025 0 0 monetary D D Dividends, Common Stock, Cash Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
Equity Securities Fv Ni Cost us-gaap/2025 0 0 monetary I D Equity Securities, FV-NI, Cost Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.
Increase Decrease In Future Policy Benefit Reserves us-gaap/2025 0 0 monetary D D Increase (Decrease) in Future Policy Benefit Reserves The change in the future policy benefit reserve balance on the balance sheet.
Investments us-gaap/2025 0 0 monetary I D Investments Sum of the carrying amounts as of the balance sheet date of all investments.
Notes Payable us-gaap/2025 0 0 monetary I C Notes Payable Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2025 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Unearned Premiums us-gaap/2025 0 0 monetary I C Unearned Premiums Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Liabilities Assumed1 us-gaap/2025 0 0 monetary D C Liabilities Assumed The fair value of liabilities assumed in noncash investing or financing activities.
Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Long Term Debt And Capital Lease Obligations us-gaap/2025 0 0 monetary I C Long-Term Debt and Lease Obligation Amount of long-term debt and lease obligation, classified as noncurrent.
Change In Life Policy Reserves Reinsurance Recoverable And Other Tax 0000020286-25-000029 1 0 monetary D D Change in life policy reserves, reinsurance recoverable and other, tax Change in life policy reserves, reinsurance recoverable and other, tax
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Actuarial Loss And Prior Service Cost Arising During Period Tax 0000020286-25-000029 1 0 monetary D D Other Comprehensive Income Loss, Pension And Other Postretirement Benefit Plans, Net Actuarial Loss And Prior Service Cost Arising During Period, Tax Other Comprehensive Income Loss, Pension And Other Postretirement Benefit Plans, Net Actuarial Loss And Prior Service Cost Arising During Period, Tax
Underwriting Acquisition And Insurance Expenses 0000020286-25-000029 1 0 monetary D D Underwriting Acquisition And Insurance Expenses Amount of commissions, insurance operating expenses, increase in deferred acquisition costs and taxes, licenses and fees.
Deferred Income Tax Liabilities us-gaap/2025 0 0 monetary I C Deferred Tax Liabilities, Gross Amount of deferred tax liability attributable to taxable temporary differences.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Revenues us-gaap/2025 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Gain Loss On Investments us-gaap/2025 0 0 monetary D C Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment.
Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 0 0 monetary D D Proceeds from Sale of Debt Securities, Available-for-Sale Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Treasury Stock Common Shares us-gaap/2025 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Treasury Stock Shares Acquired us-gaap/2025 0 0 shares D Treasury Stock, Shares, Acquired Number of shares that have been repurchased during the period and are being held in treasury.
Treasury Stock Value Acquired Cost Method us-gaap/2025 0 0 monetary D D Treasury Stock, Value, Acquired, Cost Method Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
Payments To Acquire Proceeds From Sale And Collection Of Finance Receivables 0000020286-25-000029 1 0 monetary D C Payments to acquire (proceeds from sale and collection of) finance receivables Payments to acquire (proceeds from sale and collection of) finance receivables
Additional Paid In Capital Common Stock us-gaap/2025 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Treasury Stock Value us-gaap/2025 0 0 monetary I D Treasury Stock, Value The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
Capital Lease Obligations Incurred us-gaap/2025 0 0 monetary D C Lease Obligation Incurred Amount of increase in lease obligation from new lease.
Current Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Current Income Tax Expense (Benefit) Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Increase Decrease In Deferred Policy Acquisition Costs us-gaap/2025 0 0 monetary D C Increase (Decrease) in Deferred Policy Acquisition Costs The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.
Liability For Claims And Claims Adjustment Expense us-gaap/2025 0 0 monetary I C Liability for Claims and Claims Adjustment Expense The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
Liability For Future Policy Benefits us-gaap/2025 0 0 monetary I C Liability for Future Policy Benefit, before Reinsurance Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax us-gaap/2025 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Policyholder Benefits And Claims Incurred Net us-gaap/2025 0 0 monetary D D Policyholder Benefits and Claims Incurred, Net Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.
Proceeds From Payments For Other Financing Activities us-gaap/2025 0 0 monetary D D Proceeds from (Payment for) Other Financing Activity Amount of cash inflow (outflow) from financing activity, classified as other.
Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2025 0 0 monetary D D Proceeds from Sale of Equity Securities, FV-NI Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Proceeds From Stock Options Exercised us-gaap/2025 0 0 monetary D D Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement.
Stockholders Equity Other us-gaap/2025 0 0 monetary D D Stockholders' Equity, Other This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.
Withdrawal From Contract Holders Funds us-gaap/2025 0 0 monetary D C Withdrawal from Contract Holders Funds The cash outflow for a segregated fund account during the period.
Additions To Contract Holders Funds us-gaap/2025 0 0 monetary D D Additions to Contract Holders Funds The cash inflow from a segregated fund account during the period.
Change In Short Term Investments 0000020286-25-000029 1 0 monetary D D Change in short-term investments Net Change in short-term investments
Purchase Of Treasury Shares Non Cash 0000020286-25-000029 1 0 monetary D D Purchase Of Treasury Shares Non Cash Purchase Of Treasury Shares Non Cash
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Other Liabilities us-gaap/2025 0 0 monetary I C Other Liabilities Amount of liabilities classified as other.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Taxes Paid Net us-gaap/2025 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment us-gaap/2025 0 0 monetary I C Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
Payments Of Dividends Common Stock us-gaap/2025 0 0 monetary D C Payments of Ordinary Dividends, Common Stock Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
Separate Accounts Liability us-gaap/2025 0 0 monetary I C Separate Account, Liability Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.
Shares Acquired During Period Value Employee Share Based Compensation Plans 0000020286-25-000029 1 0 monetary D D Shares Acquired During Period, Value, Employee Share-Based Compensation Plans Shares Acquired During Period, Value, Employee Share-Based Compensation Plans

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000020286-25-000029 2 3 BS 0 H Available For Sale Securities Debt Securities us-gaap/2025 Fixed maturities, at fair value (amortized cost: 2025$17,009; 2024$16,735) 0
0000020286-25-000029 2 4 BS 0 H Equity Securities Fv Ni Current And Noncurrent us-gaap/2025 Equity securities, at fair value (cost: 2025$3,964; 2024$3,953) 0
0000020286-25-000029 2 5 BS 0 H Short Term Investments us-gaap/2025 Short-term investments, at fair value (amortized cost: 2025$100; 2024$298) 0
0000020286-25-000029 2 6 BS 0 H Other Investments us-gaap/2025 Other invested assets 0
0000020286-25-000029 2 7 BS 0 H Investments us-gaap/2025 Total investments 0
0000020286-25-000029 2 8 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2025 Cash and cash equivalents 0
0000020286-25-000029 2 9 BS 0 H Accrued Investment Income Receivable us-gaap/2025 Investment income receivable 0
0000020286-25-000029 2 10 BS 0 H Notes Receivable Net us-gaap/2025 Finance receivable 0
0000020286-25-000029 2 11 BS 0 H Premiums Receivable At Carrying Value us-gaap/2025 Premiums receivable 0
0000020286-25-000029 2 12 BS 0 H Reinsurance Recoverable 0000020286-25-000029 Reinsurance recoverable 0
0000020286-25-000029 2 13 BS 0 H Prepaid Reinsurance Premiums us-gaap/2025 Prepaid reinsurance premiums 0
0000020286-25-000029 2 14 BS 0 H Deferred Policy Acquisition Costs us-gaap/2025 Deferred policy acquisition costs 0
0000020286-25-000029 2 15 BS 0 H Property Plant And Equipment Net us-gaap/2025 Land, building and equipment, net, for company use (accumulated depreciation: 2025$354; 2024$347) 0
0000020286-25-000029 2 16 BS 0 H Other Assets us-gaap/2025 Other assets 0
0000020286-25-000029 2 17 BS 0 H Separate Account Assets us-gaap/2025 Separate accounts 0
0000020286-25-000029 2 18 BS 0 H Assets us-gaap/2025 Total assets 0
0000020286-25-000029 2 21 BS 0 H Liability For Claims And Claims Adjustment Expense us-gaap/2025 Reserve for loss and loss expenses 0
0000020286-25-000029 2 22 BS 0 H Liability For Future Policy Benefits us-gaap/2025 Life policy and investment contract reserves 0
0000020286-25-000029 2 23 BS 0 H Unearned Premiums us-gaap/2025 Unearned premiums 0
0000020286-25-000029 2 24 BS 0 H Other Liabilities us-gaap/2025 Other liabilities 0
0000020286-25-000029 2 25 BS 0 H Deferred Income Tax Liabilities us-gaap/2025 Deferred income tax 0
0000020286-25-000029 2 26 BS 0 H Notes Payable us-gaap/2025 Note payable 0
0000020286-25-000029 2 27 BS 0 H Long Term Debt And Capital Lease Obligations us-gaap/2025 Long-term debt and lease obligations 0
0000020286-25-000029 2 28 BS 0 H Separate Accounts Liability us-gaap/2025 Separate accounts 0
0000020286-25-000029 2 29 BS 0 H Liabilities us-gaap/2025 Total liabilities 0
0000020286-25-000029 2 30 BS 0 H Commitments And Contingencies us-gaap/2025 Commitments and contingent liabilities (Note 12) 0
0000020286-25-000029 2 32 BS 0 H Common Stock Value us-gaap/2025 Common stock, par value$2 per share; (authorized: 2025 and 2024500 million shares; issued: 2025 and 2024198.3 million shares) 0
0000020286-25-000029 2 33 BS 0 H Additional Paid In Capital Common Stock us-gaap/2025 Paid-in capital 0
0000020286-25-000029 2 34 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Retained earnings 0
0000020286-25-000029 2 35 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Accumulated other comprehensive loss 0
0000020286-25-000029 2 36 BS 0 H Treasury Stock Value us-gaap/2025 Treasury stock at cost (202542.0 million shares and 202441.9 million shares) 1
0000020286-25-000029 2 37 BS 0 H Stockholders Equity us-gaap/2025 Total shareholders' equity 0
0000020286-25-000029 2 38 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 Total liabilities and shareholders' equity 0
0000020286-25-000029 3 1 BS 1 H Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss us-gaap/2025 Debt Securities, Available-for-sale, Amortized Cost 0
0000020286-25-000029 3 2 BS 1 H Equity Securities Fv Ni Cost us-gaap/2025 Equity Securities, FV-NI, Cost 0
0000020286-25-000029 3 3 BS 1 H Short Term Investments Available For Sale Amortized Cost Basis 0000020286-25-000029 Short-term investments, available-for-sale, amortized cost basis 0
0000020286-25-000029 3 4 BS 1 H Accumulated Depreciation Depletion And Amortization Property Plant And Equipment us-gaap/2025 Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0
0000020286-25-000029 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common Stock, Par or Stated Value Per Share (in dollars per share) 0
0000020286-25-000029 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common Stock, Shares Authorized (in shares) 0
0000020286-25-000029 3 7 BS 1 H Common Stock Shares Issued us-gaap/2025 Common Stock, Shares, Issued (in shares) 0
0000020286-25-000029 3 8 BS 1 H Treasury Stock Common Shares us-gaap/2025 Treasury Stock, Common, Shares (in shares) 0
0000020286-25-000029 4 2 IS 0 H Premiums Earned Net us-gaap/2025 Earned premiums 0
0000020286-25-000029 4 3 IS 0 H Net Investment Income us-gaap/2025 Investment income, net of expenses 0
0000020286-25-000029 4 4 IS 0 H Gain Loss On Investments us-gaap/2025 Investment gains and losses, net 0
0000020286-25-000029 4 5 IS 0 H Insurance Commissions And Fees us-gaap/2025 Fee revenues 0
0000020286-25-000029 4 6 IS 0 H Other Income us-gaap/2025 Other revenues 0
0000020286-25-000029 4 7 IS 0 H Revenues us-gaap/2025 Total revenues 0
0000020286-25-000029 4 9 IS 0 H Policyholder Benefits And Claims Incurred Net us-gaap/2025 Insurance losses and contract holders' benefits 0
0000020286-25-000029 4 10 IS 0 H Underwriting Acquisition And Insurance Expenses 0000020286-25-000029 Underwriting, acquisition and insurance expenses 0
0000020286-25-000029 4 11 IS 0 H Interest Expense us-gaap/2025 Interest expense 0
0000020286-25-000029 4 12 IS 0 H Other Cost And Expense Operating us-gaap/2025 Other operating expenses 0
0000020286-25-000029 4 13 IS 0 H Benefits Losses And Expenses us-gaap/2025 Total benefits and expenses 0
0000020286-25-000029 4 14 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 Income (Loss) Before Income Taxes 0
0000020286-25-000029 4 16 IS 0 H Current Income Tax Expense Benefit us-gaap/2025 Current 0
0000020286-25-000029 4 17 IS 0 H Deferred Income Tax Expense Benefit us-gaap/2025 Deferred 0
0000020286-25-000029 4 18 IS 0 H Income Tax Expense Benefit us-gaap/2025 Total provision (benefit) for income taxes 0
0000020286-25-000029 4 19 IS 0 H Net Income Loss us-gaap/2025 Net Income (Loss) 0
0000020286-25-000029 4 21 IS 0 H Earnings Per Share Basic us-gaap/2025 Net income (loss) basic 0
0000020286-25-000029 4 22 IS 0 H Earnings Per Share Diluted us-gaap/2025 Net income (loss) diluted 0
0000020286-25-000029 5 1 CI 0 H Net Income Loss us-gaap/2025 Net Income (Loss) 0
0000020286-25-000029 5 2 CI 0 H Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax us-gaap/2025 Change in unrealized gains and losses on investments, net of tax (benefit) of $14 and $(11), respectively 0
0000020286-25-000029 5 3 CI 0 H Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax us-gaap/2025 Amortization of pension actuarial loss (gain) and prior service cost, net of tax (benefit) of $0 and $0, respectively 0
0000020286-25-000029 5 4 CI 0 H Change In Life Policy Reserves Reinsurance Recoverable And Other Net Of Tax 0000020286-25-000029 Change in life policy reserves, reinsurance recoverable and other, net of tax (benefit) of $(3) and $10, respectively 1
0000020286-25-000029 5 5 CI 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other comprehensive income (loss) 0
0000020286-25-000029 5 6 CI 0 H Comprehensive Income Net Of Tax us-gaap/2025 Comprehensive Income (Loss) 0
0000020286-25-000029 6 1 CI 1 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax us-gaap/2025 Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax 0
0000020286-25-000029 6 2 CI 1 H Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Actuarial Loss And Prior Service Cost Arising During Period Tax 0000020286-25-000029 Other Comprehensive Income Loss, Pension And Other Postretirement Benefit Plans, Net Actuarial Loss And Prior Service Cost Arising During Period, Tax 0
0000020286-25-000029 6 3 CI 1 H Change In Life Policy Reserves Reinsurance Recoverable And Other Tax 0000020286-25-000029 Change in life policy reserves, reinsurance recoverable and other, tax 0
0000020286-25-000029 7 10 EQ 0 H Stockholders Equity us-gaap/2025 AOCI, net of tax, beginning balance 0
0000020286-25-000029 7 11 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2025 Share-based awards 0
0000020286-25-000029 7 12 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 Share-based compensation 0
0000020286-25-000029 7 13 EQ 0 H Stockholders Equity Other us-gaap/2025 Other 1
0000020286-25-000029 7 14 EQ 0 H Net Income Loss us-gaap/2025 Net Income (Loss) 0
0000020286-25-000029 7 15 EQ 0 H Dividends Common Stock Cash us-gaap/2025 Dividends declared 1
0000020286-25-000029 7 16 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other comprehensive income (loss) 0
0000020286-25-000029 7 17 EQ 0 H Treasury Stock Value Acquired Cost Method us-gaap/2025 Shares acquired - share repurchase authorization 1
0000020286-25-000029 7 18 EQ 0 H Shares Acquired During Period Value Employee Share Based Compensation Plans 0000020286-25-000029 Shares acquired - share-based compensation plans 1
0000020286-25-000029 7 19 EQ 0 H Stockholders Equity us-gaap/2025 AOCI, net of tax, ending balance 0
0000020286-25-000029 7 20 EQ 0 H Common Stock Shares Outstanding us-gaap/2025 Beginning Balance (in shares) 0
0000020286-25-000029 7 21 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2025 Share-based awards (in shares) 0
0000020286-25-000029 7 22 EQ 0 H Treasury Stock Shares Acquired us-gaap/2025 Shares acquired - share repurchase authorization (in shares) 1
0000020286-25-000029 7 23 EQ 0 H Shares Acquired During Period Employee Share Based Compensation Plans Shares 0000020286-25-000029 Shares acquired during period, Employee Share-Based Compensation Plans, Shares 1
0000020286-25-000029 7 24 EQ 0 H Common Stock Shares Outstanding us-gaap/2025 Ending Balance (in shares) 0
0000020286-25-000029 7 25 EQ 0 H Common Stock Dividends Per Share Declared us-gaap/2025 Dividends declared per common share (in dollars per share) 0
0000020286-25-000029 8 2 CF 0 H Net Income Loss us-gaap/2025 Net Income (Loss) 0
0000020286-25-000029 8 4 CF 0 H Depreciation Amortization And Other 0000020286-25-000029 Depreciation, amortization and other 0
0000020286-25-000029 8 5 CF 0 H Gain Loss On Sale Of Investments us-gaap/2025 Investment gains and losses, net 1
0000020286-25-000029 8 6 CF 0 H Interest Credited To Policy Owner Account us-gaap/2025 Interest credited to contract holders 0
0000020286-25-000029 8 7 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2025 Deferred income tax expense 0
0000020286-25-000029 8 9 CF 0 H Increase Decreasein Premiumsand Reinsurancereceivable 0000020286-25-000029 Premiums and reinsurance receivable 1
0000020286-25-000029 8 10 CF 0 H Increase Decrease In Deferred Policy Acquisition Costs us-gaap/2025 Deferred policy acquisition costs 1
0000020286-25-000029 8 11 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2025 Other assets 1
0000020286-25-000029 8 12 CF 0 H Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve us-gaap/2025 Loss and loss expense reserves 0
0000020286-25-000029 8 13 CF 0 H Increase Decrease In Future Policy Benefit Reserves us-gaap/2025 Life policy and investment contract reserves 0
0000020286-25-000029 8 14 CF 0 H Increase Decrease In Unearned Premiums us-gaap/2025 Unearned premiums 0
0000020286-25-000029 8 15 CF 0 H Increase Decrease In Other Operating Liabilities us-gaap/2025 Other liabilities 0
0000020286-25-000029 8 16 CF 0 H Increase Decrease In Deferred Income Taxes us-gaap/2025 Current income tax receivable/payable 1
0000020286-25-000029 8 17 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash provided by operating activities 0
0000020286-25-000029 8 19 CF 0 H Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 Sale, call or maturity of fixed maturities 0
0000020286-25-000029 8 20 CF 0 H Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2025 Sale of equity securities 0
0000020286-25-000029 8 21 CF 0 H Payments To Acquire Available For Sale Securities Debt us-gaap/2025 Purchase of fixed maturities 1
0000020286-25-000029 8 22 CF 0 H Payments To Acquire Equity Securities Fv Ni us-gaap/2025 Purchase of equity securities 1
0000020286-25-000029 8 23 CF 0 H Change In Short Term Investments 0000020286-25-000029 Change in short-term investments 0
0000020286-25-000029 8 24 CF 0 H Payments To Acquire Proceeds From Sale And Collection Of Finance Receivables 0000020286-25-000029 Changes in finance receivables 1
0000020286-25-000029 8 25 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2025 Investment in building and equipment 1
0000020286-25-000029 8 26 CF 0 H Payments For Proceeds From Other Investing Activities us-gaap/2025 Change in other invested assets, net 1
0000020286-25-000029 8 27 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net cash used in investing activities 0
0000020286-25-000029 8 29 CF 0 H Payments Of Dividends Common Stock us-gaap/2025 Payment of cash dividends to shareholders 1
0000020286-25-000029 8 30 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2025 Shares acquired - share repurchase authorization 1
0000020286-25-000029 8 31 CF 0 H Proceeds From Stock Options Exercised us-gaap/2025 Proceeds from stock options exercised 0
0000020286-25-000029 8 32 CF 0 H Additions To Contract Holders Funds us-gaap/2025 Contract holders' funds deposited 0
0000020286-25-000029 8 33 CF 0 H Withdrawal From Contract Holders Funds us-gaap/2025 Contract holders' funds withdrawn 1
0000020286-25-000029 8 34 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2025 Other 0
0000020286-25-000029 8 35 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash used in financing activities 0
0000020286-25-000029 8 36 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2025 Net change in cash and cash equivalents 0
0000020286-25-000029 8 37 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash and cash equivalents at beginning of year 0
0000020286-25-000029 8 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash and cash equivalents at end of period 0
0000020286-25-000029 8 40 CF 0 H Income Taxes Paid Net us-gaap/2025 Income taxes paid 0
0000020286-25-000029 8 42 CF 0 H Capital Lease Obligations Incurred us-gaap/2025 Equipment acquired under finance lease obligations 0
0000020286-25-000029 8 43 CF 0 H Purchase Of Treasury Shares Non Cash 0000020286-25-000029 Share-based compensation 0
0000020286-25-000029 8 44 CF 0 H Liabilities Assumed1 us-gaap/2025 Other assets and other liabilities 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.